The Differential Effects of Diabetes Therapy on Inflammation
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This study aims to determine if different diabetes treatments have different effects on
inflammation; in particular, kidney inflammation. This type of inflammation is common in
people with diabetes, and can lead to kidney failure. This study will investigate the effect
of different types of diabetes treatment on kidney inflammation. This will help us to decide
if certain types of medicine should be preferred in people with evidence of inflammation in
their kidneys, as this may help prevent major complications including kidney failure.
Details
Lead Sponsor:
University College Dublin
Collaborators:
Eli Lilly and Company Irish Endocrine Society Merck Sharp & Dohme Corp. Royal College of Physicians
Treatments:
Dipeptidyl-Peptidase IV Inhibitors Exenatide Glucagon Glucagon-Like Peptide 1 Liraglutide